Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Stroke prevention in atrial fibrillation

Dabigatran exilate for effective prevention of patients with atrial fibrillation.

    • Cardiology
    • Congress Reports
    • RX
  • 2 minute read

For the first time, long-term study data show that dabigatran etexilate is an effective and safe therapeutic option in the prevention of stroke in patients with atrial fibrillation among novel oral anticoagulants.

The development of the new oral anticoagulants (NOAKs) is tantamount to a breakthrough in the prevention of stroke in atrial fibrillation (AF). For a long time, vitamin K antagonists (VKA) were the effective standard therapy. However, it has always been assumed that although anticoagulant therapy results in greater protection against ischemic stroke, i.e., stroke caused by a thrombus, it also implies a significantly higher risk of bleeding. The result of the pivotal study RE-LY [1, 2] dispelled this prejudice. The study showed a significantly reduced risk of stroke and systemic embolism with dabigatran etexilate 2x daily 150 mg. The dosage 2x daily 100 mg showed a risk comparable to VKA warfarin, at the same time the risk of intracranial hemorrhage decreased significantly under both dosages. Severe bleeding rates were comparable with warfarin at the high dosage (150 mg twice daily), and rates of major bleeding decreased significantly when dabigatran etexilate 110 mg was administered twice daily.

Long-term clinical experience – RELY-ABLE

The high efficacy and balanced safety profile of dabigatran etexilate has now been confirmed by long-term data. Patients who completed the RE-LY® trial were followed up for an additional 2.3 years on average. In this continuation study, RELY-ABLE [3], patients received the same double-blinded dose of dabigatran etexilate as before. Subjects who had received warfarin in RE-LY were not part of the study.

Thus, dabigatran etexilate is the only NOAK with long-term data totaling 4.3 years in 5851 subjects. Prof. Dr. med. Thomas F. Lüscher, Zurich, presented the current evaluation, which was first published at the AHA Congress, at an event in Zurich. The data show high agreement with the results of the pivotal study: Low rates of stroke, systemic embolism and ischemic stroke indicate a high efficacy of the drug, while low rates of major bleeding and a very low number of intracranial hemorrhages indicate a favorable safety profile.

Only in November, based on these new study data, the FDA confirmed the benefit and safety of the drug [4]. According to the updated European Society of Cardiology guidelines, although VKA are effective, anticoagulation with NOAKs is recommended because of their weaknesses in use [5]. The simpler use of NOAKs has its significance mainly in practice, since no routine coagulation monitoring is required and the intake can be done independently of meals, since there is no need to fear interactions with other side effects when taking dabigatran etexilate.

Literature list at the publisher

Source: Boehringer Ingelheim press conference, December 5, 2012, Zurich.

Autoren
  • Stefan C. Schreiber
Publikation
  • CARDIOVASC
Related Topics
  • Atrial fibrillation
  • Dabigatran etexilate
  • intracranial hemorrhage
  • new oral anticoagulants
  • NOAK
  • Prevention
  • RE-LY
  • Stroke
Previous Article
  • Allergies in the family practice

Are you prepared for the allergic patient?

  • Allergology and clinical immunology
  • Dermatology and venereology
  • Education
  • RX
View Post
Next Article
  • Therapy of mental illness

Treating depression and bipolar disorder using guidelines

  • News
  • Psychiatry and psychotherapy
  • RX
View Post
You May Also Like
View Post
  • 7 min
  • From genome profiles to targeted therapies

Advances in breast cancer therapy in the age of molecular diagnostics

    • Education
    • Genetics
    • Gynecology
    • Oncology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 6 min
  • Current overview of evidence, mechanisms and clinical implications

Apolipoprotein E and neuropsychiatric symptoms in neurocognitive disorders

    • Education
    • Neurology
    • RX
    • Studies
View Post
  • 12 min
  • Parkinson's disease

Individual therapy management for an optimized outcome – an update

    • CME continuing education
    • Neurology
    • RX
    • Studies
    • Training with partner
View Post
  • 7 min
  • Rare pulmonary syndromes

Yellow nail and Swyer-James syndrome

    • CME continuing education
    • Dermatology and venereology
    • General Internal Medicine
    • Infectiology
    • Pneumology
    • RX
View Post
  • 6 min
  • Latent autoimmune diabetes in adults (LADA)

Looks like type 2, but is type 1

    • Cases
    • Education
    • Endocrinology and Diabetology
    • RX
    • Studies
View Post
  • 6 min
  • Treatment of vitiligo

Focus on patient perspective and disease activity

    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 5 min
  • Vaccine-preventable respiratory diseases

RSV and pneumococci: recommendations for risk groups

    • Congress Reports
    • General Internal Medicine
    • Infectiology
    • Pediatrics
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 5 min
  • Circadian rhythm in asthma

Chronotherapy can improve control

    • Allergology and clinical immunology
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Yellow nail and Swyer-James syndrome
  • 2
    Individual therapy management for an optimized outcome – an update
  • 3
    Doing sport without fear or risk
  • 4
    UV protection and skin cancer screening – Update 2025
  • 5
    Rare malignancy from a dermatological perspective

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.